Come up with a name for your new list and we'll add to it:
OncoResponse raised a round of funding on March 09, 2017. Investors include
HT Family Office.
OncoResponse mines the human adaptive immune system to discover therapeutic antibodies against immuno-oncology targets. By identifying candidates from the immune systems of patients who have responded…